Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Charles University, Prague
Widespread B. cenocepacia clone identified in CF patients in Czech Republic
November 4th, 2005
A widespread Burkholderia cenocepacia clone has identified in cystic fibrosis patients in the Czech Republic. According to a study from Czech Republic, "The morbidity and mortality rates in patients with cystic fibrosis (CF) are significantly affected by infections with Burkholderia cepacia complex. "In a Czech CF Center, the prevalence of the infection reached up to 30%, with the majority of patients found to be infected with Burkholderia cenocepacia (formerly genomovar III of the Burkholderia cepacia complex)." "Since B. cenocepacia is associated with patient-to-patient transmission and...
Source: Biotech Law Weekly (2005-11-04)
|
